169 related articles for article (PubMed ID: 30472670)
1. 5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging.
Martínez-Terroba E; Behrens C; Agorreta J; Monsó E; Millares L; Felip E; Rosell R; Ramirez JL; Remirez A; Torre W; Gil-Bazo I; Idoate MA; de-Torres JP; Pio R; Wistuba II; Pajares MJ; Montuenga LM
Thorax; 2019 Apr; 74(4):371-379. PubMed ID: 30472670
[TBL] [Abstract][Full Text] [Related]
2. A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients.
Martínez-Terroba E; Behrens C; de Miguel FJ; Agorreta J; Monsó E; Millares L; Sainz C; Mesa-Guzman M; Pérez-Gracia JL; Lozano MD; Zulueta JJ; Pio R; Wistuba II; Montuenga LM; Pajares MJ
J Pathol; 2018 Aug; 245(4):421-432. PubMed ID: 29756233
[TBL] [Abstract][Full Text] [Related]
3. A Two-Gene Prognostic Classifier for Early-Stage Lung Squamous Cell Carcinoma in Multiple Large-Scale and Geographically Diverse Cohorts.
Noro R; Ishigame T; Walsh N; Shiraishi K; Robles AI; Ryan BM; Schetter AJ; Bowman ED; Welsh JA; Seike M; Gemma A; Skaug V; Mollerup S; Haugen A; Yokota J; Kohno T; Harris CC
J Thorac Oncol; 2017 Jan; 12(1):65-76. PubMed ID: 27613525
[TBL] [Abstract][Full Text] [Related]
4. Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell Lung Cancer Staging.
Kratz JR; Haro GJ; Cook NR; He J; Van Den Eeden SK; Woodard GA; Gubens MA; Jahan TM; Jones KD; Kim IJ; He B; Jablons DM; Mann MJ
J Thorac Oncol; 2019 Jul; 14(7):1223-1232. PubMed ID: 30959120
[TBL] [Abstract][Full Text] [Related]
5. An updated and validated PET/CT volumetric prognostic index for non-small cell lung cancer.
Finkle JH; Penney BC; Pu Y
Lung Cancer; 2018 Sep; 123():136-141. PubMed ID: 30089584
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of the Role of PET/CT SUVmax in Prognosis and Its Correlation with
Clinicopathological Characteristics in Resectable Lung Squamous Cell Carcinoma].
Ren H; Xu W; You J; Song X; Huang H; Zhao N; Ren X; Zhang X
Zhongguo Fei Ai Za Zhi; 2016 Apr; 19(4):192-9. PubMed ID: 27118646
[TBL] [Abstract][Full Text] [Related]
7. Is the 8th edition of the Union for International Cancer Control staging of oral cancer good enough?
Vuity D; McMahon J; Takhiuddin S; Slinger C; McLellan D; Wales C; MacIver C; Thomson E; McCaul J; Hislop S; Lamb C; Stalker E; Young D
Br J Oral Maxillofac Surg; 2018 May; 56(4):272-277. PubMed ID: 29576230
[TBL] [Abstract][Full Text] [Related]
8. Oral tongue carcinoma: prognostic changes according to the updated 2020 version of the AJCC/UICC TNM staging system.
Tagliabue M; De Berardinis R; Belloni P; Gandini S; Scaglione D; Maffini F; Mirabella RA; Riccio S; Gioacchino G; Bruschini R; Chu F; Ansarin M
Acta Otorhinolaryngol Ital; 2022 Apr; 42(2):140-149. PubMed ID: 35612505
[TBL] [Abstract][Full Text] [Related]
9. Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma.
Shukla S; Evans JR; Malik R; Feng FY; Dhanasekaran SM; Cao X; Chen G; Beer DG; Jiang H; Chinnaiyan AM
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27707839
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the lung.
Koh HM; Kim DC; Kim YM; Song DH
Thorac Cancer; 2019 Dec; 10(12):2209-2217. PubMed ID: 31602798
[TBL] [Abstract][Full Text] [Related]
11. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung.
Raponi M; Zhang Y; Yu J; Chen G; Lee G; Taylor JM; Macdonald J; Thomas D; Moskaluk C; Wang Y; Beer DG
Cancer Res; 2006 Aug; 66(15):7466-72. PubMed ID: 16885343
[TBL] [Abstract][Full Text] [Related]
12. CD45RO(+) Memory T Lymphocytes--a Candidate Marker for TNM-Immunoscore in Squamous Non-Small Cell Lung Cancer.
Paulsen EE; Kilvaer T; Khanehkenari MR; Maurseth RJ; Al-Saad S; Hald SM; Al-Shibli K; Andersen S; Richardsen E; Busund LT; Bremnes R; Donnem T
Neoplasia; 2015 Nov; 17(11):839-48. PubMed ID: 26678911
[TBL] [Abstract][Full Text] [Related]
13. Construction and Validation of a Protein Prognostic Model for Lung Squamous Cell Carcinoma.
Fang X; Liu X; Weng C; Wu Y; Li B; Mao H; Guan M; Lu L; Liu G
Int J Med Sci; 2020; 17(17):2718-2727. PubMed ID: 33162799
[TBL] [Abstract][Full Text] [Related]
14. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
[TBL] [Abstract][Full Text] [Related]
15. FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.
Okabe N; Ezaki J; Yamaura T; Muto S; Osugi J; Tamura H; Imai J; Ito E; Yanagisawa Y; Honma R; Gotoh M; Watanabe S; Waguri S; Suzuki H
Int J Oncol; 2015 Mar; 46(3):999-1006. PubMed ID: 25586059
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 7th and 8th editions of the UICC/AJCC TNM staging for non-small cell lung cancer in a non-metastatic North American cohort undergoing primary radiation treatment.
Koul R; Rathod S; Dubey A; Bashir B; Chowdhury A
Lung Cancer; 2018 Sep; 123():116-120. PubMed ID: 30089581
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Conventional TNM and Novel TNMB Staging Systems for Non-Small Cell Lung Cancer.
Haro GJ; Sheu B; Cook NR; Woodard GA; Mann MJ; Kratz JR
JAMA Netw Open; 2019 Dec; 2(12):e1917062. PubMed ID: 31808928
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of ASCL2 is an independent prognostic indicator in lung squamous cell carcinoma.
Hu XG; Chen L; Wang QL; Zhao XL; Tan J; Cui YH; Liu XD; Zhang X; Bian XW
J Clin Pathol; 2016 Apr; 69(4):313-8. PubMed ID: 26483561
[TBL] [Abstract][Full Text] [Related]
19. Expression profiling defines a recurrence signature in lung squamous cell carcinoma.
Larsen JE; Pavey SJ; Passmore LH; Bowman R; Clarke BE; Hayward NK; Fong KM
Carcinogenesis; 2007 Mar; 28(3):760-6. PubMed ID: 17082175
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.
Wang J; Wu N; Zheng QF; Yan S; Lv C; Li SL; Yang Y
World J Gastroenterol; 2014 Dec; 20(48):18397-403. PubMed ID: 25561808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
